Inhibin is a peptide hormone normally produced by ovarian granulosa cells. It reaches a peak of 772 +/- 38 U per liter in the follicular phase of the menstrual cycle and is undetectable in the serum of menopausal women. To determine whether measurements of serum inhibin levels would provide a biochemical marker of the presence or progression of ovarian granulosa-cell tumors and their metastases, we measured the serum immunoreactive inhibin concentrations in six women with such tumors. Three women had been treated by hysterectomy and bilateral salpingo-oophorectomy. In the two women with residual or recurrent disease, the serum inhibin levels were abnormally elevated 5 and 20 months before the clinical manifestations of recurrence became evident. The maximal concentrations approached 3000 U per liter. The serum inhibin level remained undetectable in one patient who was disease-free for 11 years. Serum inhibin concentrations were also elevated in three women with amenorrhea and infertility that resulted from small granulosa-cell tumors. After the removal of the tumors, the serum inhibin levels in these women became normal, and fertility returned. There was a significant negative correlation between the serum concentrations of inhibin and follicle-stimulating hormone, in a manner consistent with the autonomous production of inhibin by granulosa-cell tumors. We conclude that granulosa-cell tumors produce inhibin. Since serum inhibin levels reflect the size of the tumor, measurements of inhibin can be used as a marker for primary as well as recurrent disease.
Source Information
Department of Obstetrics and Gynecology, Groningen State University Hospital, the Netherlands.
This article has been cited by other articles:
Middlebrook, B. S., Eldin, K., Li, X., Shivasankaran, S., Pangas, S. A.
(2009). Smad1-Smad5 Ovarian Conditional Knockout Mice Develop a Disease Profile Similar to the Juvenile Form of Human Granulosa Cell Tumors. Endocrinology
150: 5208-5217
[Abstract][Full Text]
Edson, M. A., Nagaraja, A. K., Matzuk, M. M.
(2009). The Mammalian Ovary from Genesis to Revelation. Endocr. Rev.
30: 624-712
[Abstract][Full Text]
Koukourakis, G. V., Kouloulias, V. E., Koukourakis, M. J., Zacharias, G. A., Papadimitriou, C., Mystakidou, K., Pistevou-Gompaki, K., Kouvaris, J., Gouliamos, A.
(2008). Granulosa Cell Tumor of the Ovary: Tumor Review. Integr Cancer Ther
7: 204-215
[Abstract]
Colombo, N., Parma, G., Zanagnolo, V., Insinga, A.
(2007). Management of Ovarian Stromal Cell Tumors. JCO
25: 2944-2951
[Abstract][Full Text]
Marca, A. L., Volpe, A.
(2007). The Anti-Mullerian hormone and ovarian cancer. Hum Reprod Update
13: 265-273
[Abstract][Full Text]
Steinmetz, R., Wagoner, H. A., Zeng, P., Hammond, J. R., Hannon, T. S., Meyers, J. L., Pescovitz, O. H.
(2004). Mechanisms Regulating the Constitutive Activation of the Extracellular Signal-Regulated Kinase (ERK) Signaling Pathway in Ovarian Cancer and the Effect of Ribonucleic Acid Interference for ERK1/2 on Cancer Cell Proliferation. Mol. Endocrinol.
18: 2570-2582
[Abstract][Full Text]
Schumer, S. T., Cannistra, S. A.
(2003). Granulosa Cell Tumor of the Ovary. JCO
21: 1180-1189
[Abstract][Full Text]
Krishnan, A., Murdock, C., Allard, J., Cisar, M., Reid, E., Nieman, L., Segars, J.
(2003). Pseudo-isolated FSH deficiency caused by an inhibin B-secreting granulosa cell tumour: Case report. Hum Reprod
18: 502-505
[Abstract][Full Text]
Welt, C., Sidis, Y., Keutmann, H., Schneyer, A.
(2002). Activins, Inhibins, and Follistatins: From Endocrinology to Signaling. A Paradigm for the New Millennium. Exp. Biol. Med.
227: 724-752
[Abstract][Full Text]
Owens, G. E., Keri, R. A., Nilson, J. H.
(2002). Ovulatory Surges of Human CG Prevent Hormone-Induced Granulosa Cell Tumor Formation Leading to the Identification of Tumor-Associated Changes in the Transcriptome. Mol. Endocrinol.
16: 1230-1242
[Abstract][Full Text]
Fuller, P. J., Zumpe, E. T., Chu, S., Mamers, P., Burger, H. G.
(2002). Inhibin-Activin Receptor Subunit Gene Expression in Ovarian Tumors. J. Clin. Endocrinol. Metab.
87: 1395-1401
[Abstract][Full Text]
Robertson, D. M., Stephenson, T., Pruysers, E., McCloud, P., Tsigos, A., Groome, N., Mamers, P., Burger, H. G.
(2002). Characterization of Inhibin Forms and Their Measurement by an Inhibin {alpha}-Subunit ELISA in Serum from Postmenopausal Women with Ovarian Cancer. J. Clin. Endocrinol. Metab.
87: 816-824
[Abstract][Full Text]
Choong, C. S., Fuller, P. J., Chu, S., Jeske, Y., Bowling, F., Brown, R., Borzi, P., Balazs, N. D., Suppiah, R., Cotterill, A. M., Payton, D., Robertson, D. M., Burger, H. G.
(2002). Sertoli-Leydig Cell Tumor of the Ovary, a Rare Cause of Precocious Puberty in a 12-Month-Old Infant. J. Clin. Endocrinol. Metab.
87: 49-56
[Abstract][Full Text]
McMullen, M. L., Cho, B.-N., Yates, C. J., Mayo, K. E.
(2001). Gonadal Pathologies in Transgenic Mice Expressing the Rat Inhibin {alpha}-Subunit. Endocrinology
142: 5005-5014
[Abstract][Full Text]
Pautier, P., Ghione, S., Brailly-Tabard, S., Lhomme, C., Morice, P., Bidart, J.M.
(2001). Are serum inhibin concentrations new markers of placental tumours in the course of chemotherapy?. Hum Reprod
16: 2434-2437
[Abstract][Full Text]
Rahman, N. A., Huhtaniemi, I. T.
(2001). Ovarian Tumorigenesis in Mice Transgenic for Murine Inhibin {{alpha}} Subunit Promoter-Driven Simian Virus 40 T-Antigen: Ontogeny, Functional Characteristics, and Endocrine Effects. Biol. Reprod.
64: 1122-1130
[Abstract][Full Text]
Minegishi, T., Kameda, T., Hirakawa, T., Abe, K., Tano, M., Ibuki, Y.
(2000). Expression of Gonadotropin and Activin Receptor Messenger Ribonucleic Acid in Human Ovarian Epithelial Neoplasms. Clin. Cancer Res.
6: 2764-2770
[Abstract][Full Text]
McCluggage, W G
(2000). Recent advances in immunohistochemistry in the diagnosis of ovarian neoplasms. J. Clin. Pathol.
53: 327-334
[Abstract][Full Text]
Long, W.-Q., Ranchin, V., Pautier, P., Belville, C., Denizot, P., Cailla, H., Lhommé, C., Picard, J.-Y., Bidart, J.-M., Rey, R.
(2000). Detection of Minimal Levels of Serum Anti-Mullerian Hormone during Follow-Up of Patients with Ovarian Granulosa Cell Tumor by Means of a Highly Sensitive Enzyme-Linked Immunosorbent Assay. J. Clin. Endocrinol. Metab.
85: 540-544
[Abstract][Full Text]
Robertson, D. M., Cahir, N., Burger, H. G., Mamers, P., McCloud, P. I., Pettersson, K., McGuckin, M.
(1999). Combined Inhibin and CA125 Assays in the Detection of Ovarian Cancer. Clin. Chem.
45: 651-658
[Abstract][Full Text]
Beamer, W. G., Shultz, K. L., Tennent, B. J., Azumi, N., Sundberg, J. P.
(1998). Mouse Model for Malignant Juvenile Ovarian Granulosa Cell Tumors. Toxicol Pathol
26: 704-710
Fuller, P. J., Verity, K., Shen, Y., Mamers, P., Jobling, T., Burger, H. G.
(1998). No Evidence of a Role for Mutations or Polymorphisms of the Follicle-Stimulating Hormone Receptor in Ovarian Granulosa Cell Tumors. J. Clin. Endocrinol. Metab.
83: 274-279
[Abstract][Full Text]
Welt, C. K., Lambert-Messerlian, G., Zheng, W., Crowley, W. F. Jr., Schneyer, A. L.
(1997). Presence of Activin, Inhibin, and Follistatin in Epithelial Ovarian Carcinoma. J. Clin. Endocrinol. Metab.
82: 3720-3727
[Abstract][Full Text]
Eagle, K., Ledermann, J. A.
(1997). Tumor Markers in Ovarian Malignancies. The Oncologist
2: 324-329
[Abstract][Full Text]
Amsterdam, A., Selvaraj, N.
(1997). Control of Differentiation, Transformation, and Apoptosis in Granulosa Cells by Oncogenes, Oncoviruses, and Tumor Suppressor Genes. Endocr. Rev.
18: 435-461
[Abstract][Full Text]
Healy, D. L., Burger, H. G., Mamers, P., Jobling, T., Bangah, M., Quinn, M., Grant, P., Day, A. J., Rome, R., Campbell, J. J.
(1993). Elevated Serum Inhibin Concentrations in Postmenopausal Women with Ovarian Tumors. NEJM
329: 1539-1542
[Abstract][Full Text]
Molitch, M. E.
(1990). Endocrinology. JAMA
263: 2639-2640
[Abstract]
Previous
